1. Genoud, S., Lappe-Siefke, C., Goebbels, S., Radtke, F.Aguet, M., Scherer, S.S., Suter, U., Nave, K.A.and Mantei, N. 2002.
Notch 1 control of oligodendrocyte differentiation in the spinal cord.
J Cell Biol. 158(4):709-718
2. Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P.E., Griffiths, I.R. and Nave, K.A. 2003
Disruption of the CNP gene uncouples oligodendroglial functions in axonal support and myelination.
Nat Genet. 33(3):366-374
3. Brockschnieder, D., Lappe-Siefke, C., Goebbels, S., Boesl, M.R., Nave, K.A. and Riethmacher, D.2004
Cell Depletion Due to Diphtheria Toxin Fragment A after Cre-Mediated Recombination.
Mol Cell Biol. 24(17):7636–7642
4. Rasband, M.N., Tayler, J., Kaga, Y., Yang, Y., Lappe-Siefke, C., Nave, K.A. and Bansal, R. 2005
CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS.
Glia 1(50):86-90
5. Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R., Wehr, M.C., Wieland, F., Ishibashi, S. and Nave, K.A. 2005
High cholesterol level is essential for myelin membrane growth.
Nat Neurosci. 4(8):468-475
6. Maas C., Tagnaouti N., Loebrich S., Behrend B., Lappe-Siefke C. and Kneussel M. 2006
Neuronal cotransport of glycine receptor and the scaffold protein gephyrin.
J Cell Biol. 172( 3):441–451
7. Kaga Y., Shoemaker W.J,. Furusho M., Bryant M., Rosenbluth J,. Pfeiffer S.E., Oh L., Rasband M., Lappe-Siefke C., Yu K., Ornitz D.M., Nave K.A. and Bansal R.2006
Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation.
J Neurosci. 26(47):12339-50
8. Kassmann C.M., Lappe-Siefke C., Baes M., Brügger B., Mildner A., Werner H.B., Natt O., Michaelis T., Prinz M., Frahm J. and Nave K.A. 2007
Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes.
Nat Genet. 39(8):969-76.
9. Lappe-Siefke C., Maas C. and Kneussel M.2008
Microinjection into cultured hippocampal neurons: a straightforward approach for controlled cellular delivery of nucleic acids, peptides and antibodies.
J Neurosci Methods. 175(1):88-95.
10. Maas C., Belgardt D., Lee H.K., Heisler F.F., Lappe-Siefke C., Magiera M.M., van Dijk J., Hausrat T.J., Janke C., Kneussel M. 2009
Synaptic activation modifies microtubules underlying transport of postsynaptic cargo.
PNAS 26 106(21):8731-6.
11. Lappe-Siefke C., Löbrich S., Hevers W., Waidmann O.B., Schweitzer M., Fehr S., Fritschy J.M., Dikic I., Eilers J., Wilson S. and Kneussel M. 2009
The ataxia (axJ) mutation causes abnormal GABAA receptor turnover in mice.
PLoS Genet. 5(9):e1000631
12. Goebbels S., Oltrogge J.H., Kemper R., Heilmann I., Bormuth I., Wolfer S., Wichert S.P., Möbius W., Liu X., Lappe-Siefke C., Rossner M.J., Groszer M., Suter U., Frahm J., Boretius S., Nave K.A.2010
Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination.
J Neurosci. 30(26):8953-64
13. Schapitz I.U., Behrend B., Pechmann Y., Lappe-Siefke C., Kneussel S.J., Wallace K.E., Stempel A.V., Buck F., Grant S.G., Schweizer M., Schmitz D., Schwarz J.R., Holzbaur E.L., Kneussel M. 2010
Neuroligin 1 is dynamically exchanged at postsynaptic sites.
J Neurosci. 30(38):12733-44.
14. Muhia M., Thies., Labonté D, Ghiretti A.E., Gromova K.V., Xompero F., Lappe-Siefke C., Hermanns-Borgmeyer I., Kuhl D., Schweizer M., Ohana O., Schwarz J.R., Holzbaur E.L.F., Kneussel M. 2016
The kinesin KIF21B regulates microtubule dynamics and is essential for neuronal morphology, synapse function, and learning and memory.
Cell Rep. 15(5):968-977.
Im Juni 2004 Verleihung der Otto-Hahn-Medaille für den wissenschaftlichen Nachwuchs durch die Max-Planck-Gesellschaft